LAVA Therapeutics N.V. (LVTX)
1.740
0.00 (0.00%)
Inactive · Last trade price on Nov 20, 2025
LAVA Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for LAVA Therapeutics stock had an average target of 1.58, with a low estimate of 1.24 and a high estimate of 2.00.
Price Target: $1.58 (-9.20%)
Analyst Consensus: Hold
* Price targets were last updated on Aug 5, 2025.
Analyst Ratings
The average analyst rating for LAVA Therapeutics stock from 4 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $1.5 → $1.24 | Hold | Maintains | $1.5 → $1.24 | -28.74% | Aug 5, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $3 → $1.5 | Strong Buy → Hold | Downgrades | $3 → $1.5 | -13.79% | Aug 5, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1.5 | Hold | Reiterates | $1.5 | -13.79% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $2 → $1.5 | Strong Buy → Hold | Downgrades | $2 → $1.5 | -13.79% | Feb 27, 2025 |
Financial Forecast
Revenue This Year
n/a
from 11.98M
Revenue Next Year
n/a
EPS This Year
-0.86
from -0.94
EPS Next Year
-0.51
from -0.86
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.88 | -0.49 | |||
| Avg | -0.86 | -0.51 | |||
| Low | -0.82 | -0.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.